Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Caroline Hutter

Showing results (31-40 of 38) with videos related to

Pageof 4
Sort By:
You have reached the last page of results.This site can display upto 38 results.
Acta Neuropathologica|October 11, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORMElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Blood Advances|September 9, 2022
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort studyPaul G Kemps, Timo C E Zondag, Helga B Arnardóttir, et al.
Hemasphere|June 9, 2026
Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for HistiocytosisFrancesco Pegoraro, Francois Chalard, Dmitry Evseev, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2019
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational StudyJean Donadieu, Islam Amine Larabi, Mathilde Tardieu, et al.
NPJ Precision Oncology|December 27, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORMHeike Peterziel, Nora Jamaladdin, Dina ElHarouni, et al.
Cancer Discovery|August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsCornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene FusionsAudrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Blood Advances|February 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patientsJean Donadieu, Dmitry Evseev, Francesco Pegoraro, et al.
Pageof 4

Showing results (31-40 of 38) with videos related to

Sort By:
Pageof 4
You have reached the last page of results.This site can display upto 38 results.
Acta Neuropathologica|October 11, 2025
Molecular characterization and clinical features of diffuse midline glioma in the pediatric precision oncology registry INFORMElke Pfaff, Kathrin Schramm, Mirjam Blattner-Johnson, et al.
Blood Advances|September 9, 2022
Clinicogenomic associations in childhood Langerhans cell histiocytosis: an international cohort studyPaul G Kemps, Timo C E Zondag, Helga B Arnardóttir, et al.
Hemasphere|June 9, 2026
Efficacy of MAPK inhibitors in children with neurodegenerative Langerhans cell histiocytosis: Results from the European Consortium for HistiocytosisFrancesco Pegoraro, Francois Chalard, Dmitry Evseev, et al.
Journal of Clinical Oncology : Official Journal of the American Society of Clinical Oncology|September 13, 2019
Vemurafenib for Refractory Multisystem Langerhans Cell Histiocytosis in Children: An International Observational StudyJean Donadieu, Islam Amine Larabi, Mathilde Tardieu, et al.
NPJ Precision Oncology|December 27, 2022
Drug sensitivity profiling of 3D tumor tissue cultures in the pediatric precision oncology program INFORMHeike Peterziel, Nora Jamaladdin, Dina ElHarouni, et al.
Cancer Discovery|August 10, 2021
The Pediatric Precision Oncology INFORM Registry: Clinical Outcome and Benefit for Patients with Very High-Evidence TargetsCornelis M van Tilburg, Elke Pfaff, Kristian W Pajtler, et al.
Clinical Cancer Research : an Official Journal of the American Association for Cancer Research|December 3, 2024
Clinical Characteristics and Outcomes of Central Nervous System Tumors Harboring NTRK Gene FusionsAudrey-Anne Lamoureux, Michael J Fisher, Lauriane Lemelle, et al.
Blood Advances|February 12, 2026
Long-term MAPK inhibition of childhood refractory-Langerhans cell histiocytosis: an observational study on 288 patientsJean Donadieu, Dmitry Evseev, Francesco Pegoraro, et al.
Pageof 4